HCPCS Level II · Outpatient PPS (temporary codes)
C9467Injection, rituximab and hyaluronidase, 10 mg
Terminated 12/31/2018
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About C9467
C9467 is an HCPCS Level II code in the C series (outpatient PPS (temporary codes)), describing injection, rituximab and hyaluronidase, 10 mg.
It was added to HCPCS effective 04/01/2018, and its current record took effect 01/01/2019.
It was terminated on 12/31/2018 and can't be billed for later dates of service.
Its Medicare coverage code is "D", meaning special Medicare coverage instructions apply.
Details
- Short description
- Inj rituximab hyaluronidase
- Date added
- 04/01/2018
- Action effective
- 01/01/2019
- Termination date
- 12/31/2018
- BETOS
- O1E
Related C94xx codes
Common questions about C9467
Is HCPCS C9467 still valid?
- No. C9467 was terminated on 12/31/2018.
Does Medicare cover C9467?
- Its coverage code is "D": special Medicare coverage instructions apply. Check the local coverage determination for your region.